The Role of Lactoferrin in Modulating Inflammation and Preventing Preterm Birth: A Narrative Review
Nutrients · 2025
DOI: 10.3390/nu17193164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Alessandro Messina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital "Degli Infermi", 13875 Ponderano, Italy. Hauptthemen laut MEDLINE: Lactoferrin, Premature Birth, Inflammation, Dietary Supplements. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality worldwide. Inflammatory cytokines, particularly IL-6, are central to PTB pathogenesis. Lactoferrin (LF), an iron-binding glycoprotein with antimicrobial and immunomodulatory properties, has been proposed as a potential protective factor against PTB. This narrative review aimed to synthesize current evidence on LF supplementation and its effects on inflammation, cytokine modulation, biochemical markers, and obstetric outcomes related to PTB.
Methods
Eight clinical studies involving pregnant women at risk of PTB were included. LF was administered orally, vaginally, or through combined regimens, with variations in dosage and duration. Reported outcomes encompassed inflammatory markers, cervical and uterine parameters, oxidative stress biomarkers, and obstetric or neonatal endpoints.
Results
Across the studies, LF supplementation was consistently associated with reduced pro-inflammatory cytokines, improvements in cervical length and uterine activity, and favorable changes in oxidative stress markers. Clinically, supplementation was linked with prolonged gestation, fewer preterm births, and reduced neonatal intensive care admissions. Immunological analyses further suggested a positive modulation of cytokine profiles in amniotic fluid.
Conclusions
LF appears to exert multifaceted immunomodulatory effects that mitigate inflammation and support pregnancy maintenance. Although findings point to its potential role in PTB prevention, they should be interpreted with caution given the limited and heterogeneous evidence. Further large-scale, multicenter randomized trials are needed to confirm efficacy and to establish optimal dosage, route, and timing of administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University Hospital "Degli Infermi", 13875 Ponderano, Italy.
- Department of Public Health and Pediatrics, University of Torino, via Santena 5bis, 10126 Turin, Italy.
- Department of Public Health and Pediatric Sciences, University of Torino School of Medicine, 10121 Turin, Italy.
- Division of Paediatrics and Neonatology, Degli Infermi Hospital, 10126 Ponderano, Italy.
ORCID-Profile: Alessandro Messina, Safae El Motarajji, Bianca Masturzo, Paolo Manzoni
Zitieren
APA
Messina, A., El Motarajji, S., Masturzo, B., & Manzoni, P. (2025). The Role of Lactoferrin in Modulating Inflammation and Preventing Preterm Birth: A Narrative Review. Nutrients. https://doi.org/10.3390/nu17193164
Vancouver
Messina A, El Motarajji S, Masturzo B, Manzoni P. The Role of Lactoferrin in Modulating Inflammation and Preventing Preterm Birth: A Narrative Review. Nutrients. 2025. doi:10.3390/nu17193164
BibTeX
@article{Messina2025,
author = {Messina, Alessandro and El Motarajji, Safae and Masturzo, Bianca and Manzoni, Paolo},
title = {The Role of Lactoferrin in Modulating Inflammation and Preventing Preterm Birth: A Narrative Review},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17193164}
}
EUVIMED